Condition
Surgical Site Infection Following Cesarean Delivery
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Not Yet Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07369700Not ApplicableEnrolling By InvitationPrimary
Evaluation of an mHealth-CHW Tool for Post-c-section Follow-up in Rural Rwanda
NCT07066254Not ApplicableNot Yet RecruitingPrimary
The Mepilex Cesarean Delivery Trial
NCT07053995Not ApplicableCompleted
EFFECTIVENESS OF PREOPERATIVE VAGINAL CLEANING IN REDUCING POST CAESAREAN INFECTIOUS MORBIDITY
NCT01870583Not ApplicableCompletedPrimary
Comparison of Surgical Skin Preps During Cesarean Deliveries
Showing all 4 trials